Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained (Deficit)
Attributable to Non- controlling Interest
Beginning balance (in shares) at Dec. 31, 2019   8,304,030      
Beginning balance at Dec. 31, 2019 $ 50,193 $ 0 $ 77,431 $ (31,933) $ 4,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (10,186)     (9,282) (904)
Stock-based compensation expense 416   416    
Ending balance (in shares) at Mar. 31, 2020   8,304,030      
Ending balance at Mar. 31, 2020 40,423 $ 0 77,847 (41,215) 3,791
Beginning balance (in shares) at Dec. 31, 2019   8,304,030      
Beginning balance at Dec. 31, 2019 50,193 $ 0 77,431 (31,933) 4,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (25,047)        
Ending balance (in shares) at Sep. 30, 2020   10,658,844      
Ending balance at Sep. 30, 2020 36,120 $ 0 88,609 (54,522) 2,033
Beginning balance (in shares) at Dec. 31, 2019   8,304,030      
Beginning balance at Dec. 31, 2019 50,193 $ 0 77,431 (31,933) 4,695
Ending balance (in shares) at Dec. 31, 2020   24,883,024      
Ending balance at Dec. 31, 2020 95,250 $ 0 164,264 (69,014)  
Beginning balance (in shares) at Mar. 31, 2020   8,304,030      
Beginning balance at Mar. 31, 2020 40,423 $ 0 77,847 (41,215) 3,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (8,753)     (8,009) (744)
Stock issuances (in shares)   2,015,148      
Stock issuance 14,021   14,021    
Stock-based compensation expense 296   296    
Share repurchase (in shares)   (233,788)      
Share repurchase (6,250)   (6,250)    
Stock option exercise (in shares)   47,607      
Stock option exercise 12   12    
Ending balance (in shares) at Jun. 30, 2020   10,132,997      
Ending balance at Jun. 30, 2020 39,749 $ 0 85,926 (49,224) 3,047
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,108)     (5,094) (1,014)
Stock issuances (in shares)   559,226      
Stock issuance 3,817   3,817    
Stock-based compensation expense 489   489    
Stock option exercise (in shares)   32,880      
Stock option exercise 8   8    
Share exchange (in shares)   (66,259)      
Deferred stock issuance costs (1,835)   (1,631) (204)  
Ending balance (in shares) at Sep. 30, 2020   10,658,844      
Ending balance at Sep. 30, 2020 36,120 $ 0 88,609 (54,522) $ 2,033
Beginning balance (in shares) at Dec. 31, 2020   24,883,024      
Beginning balance at Dec. 31, 2020 95,250 $ 0 164,264 (69,014)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (13,765)     (13,765)  
Founders earnout shares vested (in shares)   570,212      
Issuance of common shares upon vesting of RSUs (in shares) 7,713        
Stock-based compensation expense $ 1,550   1,550    
Exercise of warrants (in shares)   122,639      
Exercise of warrants 1,410   1,410    
Ending balance (in shares) at Mar. 31, 2021   25,583,588      
Ending balance at Mar. 31, 2021 84,445 $ 0 167,224 (82,779)  
Beginning balance (in shares) at Dec. 31, 2020   24,883,024      
Beginning balance at Dec. 31, 2020 95,250 $ 0 164,264 (69,014)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (21,726)        
Stock option exercise (in shares) 40,942        
Ending balance (in shares) at Sep. 30, 2021   26,168,044      
Ending balance at Sep. 30, 2021 $ 87,671 $ 0 178,411 (90,740)  
Beginning balance (in shares) at Mar. 31, 2021   25,583,588      
Beginning balance at Mar. 31, 2021 84,445 $ 0 167,224 (82,779)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (8,956)     (8,956)  
Issuance of common shares upon vesting of RSUs (in shares) 5,111        
Stock-based compensation expense $ 3,323   3,323    
Stock option exercise (in shares)   40,942      
Stock option exercise 10   10    
Ending balance (in shares) at Jun. 30, 2021   25,629,641      
Ending balance at Jun. 30, 2021 78,822 $ 0 170,557 (91,735)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 995     995  
Stock-based compensation expense 3,264   3,264    
Conversions of debt to common stock, net of debt issuance (in shares)   538,403      
Conversions of debt to common stock, net of debt issuance 4,590   4,590    
Ending balance (in shares) at Sep. 30, 2021   26,168,044      
Ending balance at Sep. 30, 2021 $ 87,671 $ 0 $ 178,411 $ (90,740)